Laurus Labs has said it has received the license from Defence Research and Development Organisation (DRDO) to manufacture and market COVID-19 treatment drug 2-Deoxy-D-Glucose (2DG)....
Laurus Labs has received Form 483 with zero observations for Unit 2 (the formulations unit). The United States Food and Drug Administration (USFDA) has successfully...